Published by Josh White on 22nd March 2023
(Sharecast News) - Arecor Therapeutics announced the start of the phase one clinical trial for its ultra-rapid acting insulin candidate 'AT278' on Wednesday, with the first patient being dosed.
URL: http://www.digitallook.com/dl/news/story/33386611/...